NeuroPace, Inc. NPCE
12.31 USD -0.03 (-0.24%)
At closeNov 3, 2026, 4:01 PM EST
12.31 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
12.00 Day range 12.64
9.23 52-week range 19.60
- YTD
- -20.27%
- 1 year
- +30.96%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 16.17 +31.3% upside
Now 12.31
- Target (low)
- 13.00
- Target (mean)
- 16.17
- Target (high)
- 20.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy1
- Buy5
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.24798 | -0.27 – -0.21 | -0.23 | -7.8% | 20.91M | +16.1% | 5 |
| Next quarter | -0.2475 | -0.30 – -0.15 | -0.32 | +22.7% | 21.13M | +16.6% | 4 |
| Current year | -1.01 | -1.03 – -0.97 | -1.27 | +20.7% | 79.24M | +21.1% | 5 |
| Next year | -0.90028 | -1.03 – -0.70 | -1.01 | +10.7% | 90.77M | +14.5% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 17, 2024 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 13, 2024 | Wells Fargo | Maintained | Overweight | Overweight |
| Aug 14, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 14, 2024 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 15, 2024 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| May 9, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Mar 14, 2024 | Wells Fargo | Upgrade | Equal-Weight | Overweight |
| Mar 12, 2024 | JP Morgan | Maintained | Overweight | Overweight |
| Mar 6, 2024 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Mar 6, 2024 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Feb 22, 2024 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jan 30, 2024 | Leerink Partners | Initiated | — | Outperform |
| Dec 27, 2023 | Lake Street | Reiterated | Buy | Buy |
| Dec 4, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Nov 14, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Nov 10, 2023 | Cantor Fitzgerald | Initiated | — | Overweight |
| Nov 7, 2023 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 4, 2023 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Aug 24, 2023 | Morgan Stanley | Upgrade | Underweight | Equal-Weight |
| May 5, 2023 | Morgan Stanley | Maintained | — | Underweight |
| Mar 3, 2023 | Morgan Stanley | Maintained | — | Underweight |
| Feb 22, 2023 | Lake Street | Initiated | — | Buy |
| Jan 6, 2023 | Morgan Stanley | Maintained | — | Underweight |
| Oct 11, 2022 | Morgan Stanley | Maintained | — | Underweight |
| Jul 15, 2022 | Morgan Stanley | Maintained | — | Underweight |
| May 13, 2022 | Morgan Stanley | Maintained | — | Underweight |
| May 13, 2022 | Wells Fargo | Maintained | — | Equal-Weight |
| Apr 6, 2022 | Wolfe Research | Initiated | — | Outperform |
| Mar 11, 2022 | Wells Fargo | Maintained | — | Equal-Weight |
| Mar 11, 2022 | SVB Leerink | Maintained | — | Outperform |